The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1241
August 14, 2006
View Complete Issue         Table of Contents 2019 
Varenicline (Chantix) for Tobacco Dependence
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Varenicline (Chantix) for Tobacco Dependence
August 14, 2006 (Issue: 1241)
Varenicline tartrate (Chantix - Pfizer) is now available for oral treatment of tobacco dependence. Some other drugs for this indication are listed in this article.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Varenicline (Chantix) for Tobacco Dependence
Article code: 1241b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.